Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000025

Options or other derivatives

  • Director acquired 32,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Zeiher Bernhardt G Director 2023-04-04 Grant or award · Stock Option (Right to Buy) +32,000 32,000 D: show line 1 in the form
Loading xslF345X04/wf-form4_168064301724542.xml…